- Correction
- Open access
- Published:
Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer
Biomarker Research volume 11, Article number: 95 (2023)
Correction: Biomark Res 7, 16 (2019)
https://doi.org/10.1186/s40364-019-0168-9
The original article [1] contains the following errors:
-
1)
The ordinate scale is displayed incorrectly in Fig. 2D-F.
- 2)
-
3)
Table 3 contained data in the ‘HR’, ‘95% CI’, and ‘P-value’ columns of the ‘Adjuvant chemotherapy’ and ‘Non-chemotherapy’ rows that should have been deleted.
Transcriptional levels of PRDXs in various BrCa subclasses. The transcriptional level of PRDXs in BrCa patients with different subclasses, PRDXs mRNA was significantly downregulated (PRDX3) or upregulated (other PRDXs) in HER2-positive and triple-negative BrCa tissues compared with luminal BrCa tissues. a PRDX1. b PRDX2. c PRDX3. d PRDX4. e PRDX5. f PRDX6
Correlation between the genetic alterations of PRDXs and mRNA levels in BrCa tissues. a Oncoprint in cBioPortal database exhibited the proportion and distribution of specimens with genetic alterations in PRDXs. The Figure was cropped on the right to exclude specimens without any alterations. b-g Copy gain (gain and amplification) of PRDXs was associated with notably upregulated PRDXs mRNA levels compared with the copy-neutral (diploid) and copy-loss (shallow deletion and deep deletion) cases. b PRDX1. c PRDX2. d PRDX3. e PRDX4. f PRDX5. g PRDX6
The corrected Fig. 2, Fig. 3, and Table 3 all appear ahead. The authors apologize for this error and state that this does not change the scientific conclusion in any way.
Reference
Mei J, Hao L, Liu X, et al. Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. Biomark Res. 2019;7:16. https://doi.org/10.1186/s40364-019-0168-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Mei, J., Hao, L., Liu, X. et al. Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. Biomark Res 11, 95 (2023). https://doi.org/10.1186/s40364-023-00541-1
Published:
DOI: https://doi.org/10.1186/s40364-023-00541-1